Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cantor Fitzgerald
Argus Health
Healthtrust
US Department of Justice
Express Scripts
Covington
Boehringer Ingelheim
Merck

Generated: December 19, 2018

DrugPatentWatch Database Preview

Mitsubishi Tanabe Company Profile

« Back to Dashboard

What is the competitive landscape for MITSUBISHI TANABE, and what generic alternatives to MITSUBISHI TANABE drugs are available?

MITSUBISHI TANABE has one approved drug.

There is one US patent protecting MITSUBISHI TANABE drugs.

There are seven patent family members on MITSUBISHI TANABE drugs in six countries.

Summary for Mitsubishi Tanabe
International Patents:7
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Patent Litigation for Mitsubishi Tanabe: See patent lawsuits for Mitsubishi Tanabe

Drugs and US Patents for Mitsubishi Tanabe

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mitsubishi Tanabe RADICAVA edaravone SOLUTION;INTRAVENOUS 209176-001 May 5, 2017 RX Yes Yes 6,933,310 ➤ Try a Free Trial ➤ Try a Free Trial
Mitsubishi Tanabe RADICAVA edaravone SOLUTION;INTRAVENOUS 209176-001 May 5, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Mitsubishi Tanabe RADICAVA edaravone SOLUTION;INTRAVENOUS 209176-001 May 5, 2017 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Mitsubishi Tanabe Drugs

Country Document Number Estimated Expiration
European Patent Office 1405637 ➤ Try a Free Trial
Austria 303808 ➤ Try a Free Trial
Japan 3758164 ➤ Try a Free Trial
Japan WO2002034264 ➤ Try a Free Trial
World Intellectual Property Organization (WIPO) 0234264 ➤ Try a Free Trial
Germany 60022560 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Citi
Dow
Chinese Patent Office
Boehringer Ingelheim
Cipla
Teva
Covington
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.